Bank of America’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bank of America’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-400,000	Closed	-$732K	–	7508
2018 Q1	$732K	Buy	+400,000	New	+$845K	﹤0.01%	4581

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America's SGYP Position: Q1 2019 in Review

Bank of America sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 532,671 shares — an estimated $60K sold.

Bank of America first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $489K in Q1 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Bank of America reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Bank of America sold 532,671 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $60K.
Bank of America first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
Bank of America's Synergy Pharmaceuticals, Inc Common Stock position peaked at $489K in Q1 2017.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Bank of America's 13F filing for Q1 2019, filed 15 May 2019.